Literature DB >> 15325803

The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis.

Soo-Cheon Chae1, Young-Ran Park, Seung-Cheol Shim, Kyung-Sik Yoon, Hun-Taeg Chung.   

Abstract

The family of T-cell immunoglobulin domain and mucin domain (TIM) proteins is identified to be expressed on T cells. A member of TIM family, TIM-3 is selectively expressed on the surface of differentiated Th1 cells. TIM-3 might have an important role in the induction of autoimmune diseases by regulating macrophage activation and interacts with TIM-3 ligand to regulate Th1 responses. In the present study, we analyzed the association of the genotype and allele frequencies between rheumatoid arthritis (RA) patients and the controls without RA using large samples size at the -1516G>T, -574T>G and 4259G>T polymorphic sites of human Tim-3 gene. We further investigated the relationships between the genotypes of each single nucleotide polymorphisms (SNPs) and C-reactive protein (CRP) or rheumatoid factor (RF) levels in RA patients. The genotype and allele frequencies of the -574T>G (P = 0.001 and 0.001, respectively) as well as the 4259G>T (P = 0.001 ands 0.003, respectively) between RA patients and non-RA controls were significantly different. These results strongly suggest that -574T>G and 4259G>T polymorphism of the Tim-3 might be associated with susceptibility to RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325803     DOI: 10.1016/j.imlet.2004.06.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  21 in total

1.  Expression of human T cell immunoglobulin domain and mucin-3 on kidney tissue from immunoglobulin A nephropathy patients.

Authors:  Xiangdong Yang; Zhao Hu; Xiyan Xia; Junhui Zhen; Xuewei Zhuang; Tao Peng
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

2.  T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer.

Authors:  Danian Tong; Yujia Zhou; Wei Chen; Yang Deng; Lei Li; Zhenyi Jia; Dachuan Qi
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

Review 3.  TIM polymorphisms--genetics and function.

Authors:  J Lee; B Phong; A M Egloff; L P Kane
Journal:  Genes Immun       Date:  2011-11-03       Impact factor: 2.676

4.  Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4+ T cells in rheumatoid arthritis.

Authors:  Jaejoon Lee; Eun-Jung Park; Jung Won Noh; Ji Won Hwang; Eun-Kyung Bae; Joong Kyong Ahn; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

5.  T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas.

Authors:  Haihan Song; Shaolin Ma; Zhanshan Cha; Lei Chen; Danian Tong; Lan Ma; Weiguo Song; Jianwen Bai
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 6.  TIM-3 as a new therapeutic target in systemic lupus erythematosus.

Authors:  Hai-Feng Pan; Ning Zhang; Wen-Xian Li; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

7.  Imbalanced expression of T-bet and T cell immunoglobulin mucin-3 in patients with aplastic anaemia.

Authors:  Ning-ning Shan; Yu Hu; Xin Liu; Xin Wang; Dai Yuan; Ying Li
Journal:  J Clin Immunol       Date:  2013-01-19       Impact factor: 8.317

8.  T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer.

Authors:  Jianwen Bai; Xiaoyan Li; Danian Tong; Weiwei Shi; Haihan Song; Qinchuan Li
Journal:  Tumour Biol       Date:  2013-01-29

Review 9.  The costimulatory role of TIM molecules.

Authors:  Roselynn Rodriguez-Manzanet; Rosemarie DeKruyff; Vijay K Kuchroo; Dale T Umetsu
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

10.  TIM-3 polymorphisms in type 1 diabetes families.

Authors:  Patrick Brück; Elizabeth Ramos-Lopez; Wiebke Bartsch; Angelika Böhme; Klaus Badenhoop
Journal:  J Hum Genet       Date:  2008-04-10       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.